News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement Yael L. Maxwell April 26, 2021
News Daily News Primary PCI Underused but Just as Effective in Cancer Patients With STEMI Michael O'Riordan February 04, 2021